Examining the Efficacy of Kiko Exercises on the Prevention of Migraine Headaches

Migraine Headache Clinical Trial

Official title:

Pilot Study Examining the Efficacy of Kiko Exercises on the Prevention of Migraine Headaches

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03651583
• Other study ID #: Kiko Protocol 01
• Status: Completed
• Phase: Early Phase 1
• Start date: January 2006
• Est. completion date: May 2006

Study information

• Verified date: August 2018
• Source: Regional Clinical Research
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This pilot study hopes to show that after 3 months of Kiko training, Kiko naive patients with migraine will have a decrease in the frequency and severity of their migraines.

Description:

3.1 Study Design

Eligible subjects in this pilot study will be taught a series of Kiko exercises. Subjects who meet inclusion and exclusion criteria at the screening visit will be given a diary in which they will document their migraine frequency and severity for one month. Once subject diaries are complete, subjects will meet for a group lesson to learn the background of Kiko and study exercises. A DVD or videotape will be issued for subjects to use during practice at home. Subjects will maintain a diary of their migraine headaches, as well as a diary of their exercise routines. Subjects will meet weekly to reinforce training and encourage training continuation. Diaries will be collected at the end of the first, second, and third months.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 13
• Est. completion date: May 2006
• Est. primary completion date: May 2006
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

• Males or females, 18 to 70 years of age, with at least a 1-year history of migraine headaches

• With or without aura, (IHS criteria 1.1 and 1.2), who have experienced at least 4 migraines a month, or 2-3 migraines a month that last 2-3 days per attack in each of the 3 months prior to screening.

• The subjects must be naïve to Kiko and Qigong training.

Exclusion Criteria:

1. Subject has any cardiac condition, as determined by the investigator, that would preclude safe participation in a low level exercise program.

2. Uncontrolled hypertension at screening (sitting systolic pressure >160 mmHg, diastolic pressure >95 mmHg.)

3. Subject has had tension-type headaches, >15 days/month in any of the 3 months prior to screening.

4. Subject has more than 8 migraines per month, or more than 16 days of migraine per month.

5. Subject is pregnant or expects to become pregnant during the course of the trial.

6. Subject has substance or alcohol abuse within the the last year which, in the investigator's judgement, will interfere with the study conduct, cooperation or evaluation and interpretation of the study results.

7. Subject has any concurrent medical or psychological condition that, in the investigator's opinion, may affect the interpretation of efficacy or safety data or which otherwise contraindicates participation in the trial.

8. Subject has participated in an investigational drug trial within the previous 4 weeks.

9. Subject uses pain medication in excess of 40 doses of over the counter medication and/or prescription pain medication per month to treat headaches of any type.

10. Subject is unable to differentiate between migraine and non-migraine headaches.

Related Conditions & MeSH terms

• Headache
• Migraine Disorders
• Migraine Headache

Intervention

Behavioral:
• Kiko exercises-combines breathing and movement

Locations

Country	Name	City	State
United States	Endwell Family Physicians	Endwell	New York

Sponsors (1)

Lead Sponsor	Collaborator
Regional Clinical Research

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in Migraine Frequency and Severity from Baseline	Change in Migraine Frequency and Severity from Baseline on LIkert Scale 1-4	3 months
Secondary	Change in number of headache free days	Change in number of headache free days from baseline based on Diary Data	3 months
Secondary	Change in number of migraine free days	Change in number of Migraine free days from baseline based on diary data	3 months
Secondary	Change in overall quality of life	Change in quality of life from baseline based on LIkert scale 1-2	3 month
Secondary	Subject satisfaction with Kiko training	Satisfaction measurement of training based on LIkert scale 1-5	3 months